Trial · NCT01030718
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Studies CA180-031 and -036 Combined | STARTED | CML - Chronic Phase (CML-CP) | 30 | |
| Studies CA180-031 and -036 Combined | STARTED | CML - Accelerated Phase and Blast Phase (CML-AP/BP) | 11 | |
| Studies CA180-031 and -036 Combined | STARTED | Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL) | 13 | |
| Studies CA180-031 and -036 Combined | COMPLETED | CML - Chronic Phase (CML-CP) | 26 | |
| Studies CA180-031 and -036 Combined | COMPLETED | CML - Accelerated Phase and Blast Phase (CML-AP/BP) | 2 | |
| Studies CA180-031 and -036 Combined | COMPLETED | Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL) | 1 | |
| Studies CA180-031 and -036 Combined | NOT COMPLETED | CML - Chronic Phase (CML-CP) | 4 | |
| Studies CA180-031 and -036 Combined | NOT COMPLETED | CML - Accelerated Phase and Blast Phase (CML-AP/BP) | 9 | |
| Studies CA180-031 and -036 Combined | NOT COMPLETED | Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL) | 12 | |
| Study CA180-036 Only | STARTED | CML - Chronic Phase (CML-CP) | 29 | |
| Study CA180-036 Only | STARTED | CML - Accelerated Phase and Blast Phase (CML-AP/BP) | 9 | |
| Study CA180-036 Only | STARTED | Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL) | 6 | |
| Study CA180-036 Only | COMPLETED | CML - Chronic Phase (CML-CP) | 26 | |
| Study CA180-036 Only | COMPLETED | CML - Accelerated Phase and Blast Phase (CML-AP/BP) | 2 | |
| Study CA180-036 Only | COMPLETED | Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL) | 1 | |
| Study CA180-036 Only | NOT COMPLETED | CML - Chronic Phase (CML-CP) | 3 | |
| Study CA180-036 Only | NOT COMPLETED | CML - Accelerated Phase and Blast Phase (CML-AP/BP) | 7 | |
| Study CA180-036 Only | NOT COMPLETED | Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL) | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01030718/flow